Neng-Wen Ke
Overview
Explore the profile of Neng-Wen Ke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhao Y, Chen L, Yang X, Dong J, Wu W, Chen D, et al.
Sichuan Da Xue Xue Bao Yi Xue Ban
. 2020 Sep;
51(5):643-649.
PMID: 32975078
Objective: To examine copper transporter 1 (CTR1) expression in pancreatic carcinoma cells, orthotopic xenograft pancreatic tumor model and clinical samples, and verify the effect of copper chelating agent ammonium tetrathiomolybdate...
12.
Yang M, Zeng L, Ke N, Tan C, Tian B, Liu X, et al.
BMC Cancer
. 2020 Sep;
20(1):906.
PMID: 32962649
Background: Pancreatic neuroendocrine neoplasms (p-NENs) are a group of highly heterogeneous tumors with distinct clinicopathological features and long-term prognosis. In 2017, in order to better stratify patients into prognostic groups...
13.
Chen H, Zhou Y, Chen Y, Wang X, Zhang H, Ke N, et al.
World J Gastroenterol
. 2020 Aug;
26(25):3638-3649.
PMID: 32742132
Background: Pancreatic neuroendocrine neoplasms (pNENs) that produce hormones leading to symptoms are classified as functional tumors, while others are classified as nonfunctional tumors. The traditional view is that functionality is...
14.
Tan Q, Wang X, Yang L, Chen Y, Tan C, Ke N, et al.
ANZ J Surg
. 2020 Jun;
90(10):2026-2031.
PMID: 32590888
Background: Owing to the limited prevalence and heterogeneity, it is difficult to predict long-term survival of non-functional pancreatic neuroendocrine tumours (NF-PNETs).This study aimed to evaluate the factors predicting disease-specific survival...
15.
Tan Q, Wang X, Yang L, Chen Y, Tan C, Zhu X, et al.
Medicine (Baltimore)
. 2020 Jun;
99(24):e20324.
PMID: 32541455
Although pancreatic neuroendocrine tumors (PNETs) are generally considered to have a favorable overall prognosis after resection, disease recurrence has been observed. Few studies have specifically addressed recurrence after resection of...
16.
Yang M, Zeng L, Ke N, Tan C, Tian B, Liu X, et al.
Pancreas
. 2020 May;
49(5):e42-e43.
PMID: 32433414
No abstract available.
17.
Hui B, Qiu J, Liu J, Ke N
Comput Math Methods Med
. 2020 May;
2020:2761627.
PMID: 32377222
Background: In a pathological examination of pancreaticoduodenectomy for pancreatic head adenocarcinoma, a resection margin without cancer cells in 1 mm is recognized as R0; a resection margin with cancer cells...
18.
Wang X, Shan Y, Tan Q, Tan C, Zhang H, Liu J, et al.
Cancer Cell Int
. 2020 Mar;
20:63.
PMID: 32140076
Background: Pancreatic ductal adenocarcinoma (PDA) is one of the most serious causes of death in the world due to its high mortality and inefficacy treatments. MEX3A was first identified in...
19.
Yang M, Zhang Y, Zeng L, Ke N, Tan C, Tian B, et al.
Pancreas
. 2019 May;
48(5):613-621.
PMID: 31091206
Objectives: We aimed to validate the novel American Joint Committee on Cancer (AJCC) eighth edition staging manual for well-differentiated (G1/G2) pancreatic neuroendocrine tumors (pNETs). Methods: Data of eligible patients were...
20.
Yang M, Zhang Y, Zeng L, Ke N, Tan C, Tian B, et al.
Eur J Surg Oncol
. 2019 Jan;
45(6):1054-1060.
PMID: 30661921
Background And Objective: We aimed to compare the two new defined tumor-node-metastasis (TNM) systems in the American Joint Committee on Cancer (AJCC) 8th staging manual for overall survival (OS) analysis...